Total Payments
$1,206
2024 Payments
$250.19
Companies
7
Transactions
35
Medicare Patients
299
Medicare Billing
$69,342
Payment Breakdown by Category
Food & Beverage$639.98 (53.1%)
Travel$566.29 (46.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $639.98 | 34 | 53.1% |
| Travel and Lodging | $566.29 | 1 | 46.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Prytime Medical Devices, Inc. | $590.99 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $502.69 | 28 | $0 (2024) |
| Aroa Biosurgery Incorporated | $42.41 | 1 | $0 (2022) |
| Genentech USA, Inc. | $22.21 | 1 | $0 (2024) |
| Lilly USA, LLC | $16.68 | 1 | $0 (2024) |
| TELA Bio, Inc. | $15.82 | 1 | $0 (2024) |
| AbbVie Inc. | $15.47 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $250.19 | 15 | GlaxoSmithKline, LLC. ($195.48) |
| 2023 | $112.20 | 5 | GlaxoSmithKline, LLC. ($112.20) |
| 2022 | $72.02 | 3 | Aroa Biosurgery Incorporated ($42.41) |
| 2021 | $69.38 | 4 | GlaxoSmithKline, LLC. ($53.91) |
| 2020 | $35.21 | 2 | GlaxoSmithKline, LLC. ($35.21) |
| 2019 | $31.25 | 2 | GlaxoSmithKline, LLC. ($31.25) |
| 2018 | $24.70 | 1 | Prytime Medical Devices, Inc. ($24.70) |
| 2017 | $611.32 | 3 | Prytime Medical Devices, Inc. ($566.29) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $2.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Neurology | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: IMMUNOLOGY | ||||||
| 06/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.61 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | TELA Bio, Inc. | OviTex 2S (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Surgical Mesh | ||||||
| 05/27/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: IMMUNOLOGY | ||||||
| 03/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2022 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $42.41 | General |
| 10/27/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 136 | $171,275 | $17,482 |
| 2022 | 4 | 91 | 168 | $220,450 | $21,633 |
| 2021 | 3 | 72 | 124 | $159,714 | $16,590 |
| 2020 | 3 | 55 | 100 | $136,433 | $13,637 |
Total Patients
299
Total Services
528
Medicare Billing
$69,342
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 26 | 69 | $152,628 | $11,902 | 7.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $11,847 | $3,472 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 34 | $6,800 | $2,109 | 31.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 32 | 91 | $201,292 | $15,970 | 7.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 47 | $9,400 | $2,715 | 28.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 19 | $6,821 | $2,054 | 30.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $2,937 | $893.88 | 30.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 25 | 65 | $143,780 | $11,747 | 8.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 26 | $9,334 | $2,899 | 31.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 33 | $6,600 | $1,945 | 29.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 24 | 57 | $126,084 | $10,482 | 8.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 32 | $6,400 | $1,904 | 29.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 11 | 11 | $3,949 | $1,251 | 31.7% |
About Dr. Laura Moore, MD
Dr. Laura Moore, MD is a Surgical Critical Care healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295767374.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Moore, MD has received a total of $1,206 in payments from pharmaceutical and medical device companies, with $250.19 received in 2024. These payments were reported across 35 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($639.98).
As a Medicare-enrolled provider, Moore has provided services to 299 Medicare beneficiaries, totaling 528 services with total Medicare billing of $69,342. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical Critical Care
- Location Houston, TX
- Active Since 07/07/2006
- Last Updated 11/04/2009
- Taxonomy Code 2086S0102X
- Entity Type Individual
- NPI Number 1295767374
Products in Payments
- ER-REBOA (Device) $590.99
- NUCALA (Biological) $337.29
- TRELEGY ELLIPTA (Drug) $85.41
- ANORO (Drug) $45.03
- Evrysdi (Drug) $22.21
- BREO ELLIPTA (Drug) $17.64
- BREO (Drug) $17.32
- MOUNJARO (Drug) $16.68
- OviTex 2S (Device) $15.82
- UBRELVY (Drug) $15.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgical Critical Care Doctors in Houston
Rondel Albarado, M.d, M.D
Surgical Critical Care — Payments: $344,414
Surgical Critical Care $344,414
Ryan Dumas, Md, MD
Surgical Critical Care — Payments: $39,785
Surgical Critical Care $39,785
Daniel Bonville, Do, DO
Surgical Critical Care — Payments: $29,413
Surgical Critical Care $29,413
Dr. Robert Ochoa, Md, MD
Surgical Critical Care — Payments: $14,828
Surgical Critical Care $14,828
Alexi Bloom
Surgical Critical Care — Payments: $11,740
Surgical Critical Care $11,740
Samual Todd, Md, MD
Surgical Critical Care — Payments: $1,760
Surgical Critical Care $1,760